Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation
Authors
Keywords
NK cells, T cells, Haplotypes, Leukemias, Multivariate analysis, Stem cell transplantation, Genotyping, Cell transplantation
Journal
PLoS One
Volume 11, Issue 6, Pages e0158242
Publisher
Public Library of Science (PLoS)
Online
2016-06-25
DOI
10.1371/journal.pone.0158242
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts
- (2016) Rosy Dabas et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Rabbit Anti–T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation
- (2015) Jan Storek et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality
- (2015) A. Mancusi et al. BLOOD
- Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis
- (2015) A B M Lim et al. BONE MARROW TRANSPLANTATION
- The Role of the Killer Cell Immunoglobulin-Like Receptor (KIR) “Missing Self” Model in Unrelated Donor HSCT: A Meta-analysis
- (2015) S. Wu et al. TRANSPLANTATION PROCEEDINGS
- Immune Cell Subset Counts Associated with Graft-versus-Host Disease
- (2014) Peter J. Podgorny et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
- (2014) N. N. Shah et al. BLOOD
- Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3
- (2014) A. K. Moesta et al. JOURNAL OF IMMUNOLOGY
- Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia
- (2014) S. Cooley et al. JOURNAL OF IMMUNOLOGY
- Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
- (2014) Faviel F. González-Galarza et al. NUCLEIC ACIDS RESEARCH
- Fludarabine, Busulfan, Antithymocyte Globulin, and Total Body Irradiation for Pretransplantation Conditioning in Acute Lymphoblastic Leukemia: Excellent Outcomes in All but Older Patients with Comorbidities
- (2012) Andrew Daly et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD
- (2012) L M Pratt et al. BONE MARROW TRANSPLANTATION
- Immune reconstitution after hematopoietic cell transplantation
- (2012) Mark Bosch et al. CURRENT OPINION IN HEMATOLOGY
- Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation
- (2012) Mark Bosch et al. CYTOTHERAPY
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions
- (2011) B. Foley et al. BLOOD
- Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors
- (2011) Mette Hoegh-Petersen et al. CYTOTHERAPY
- Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies
- (2010) Kate Stringaris et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients
- (2010) Alejandra Ugarte-Torres et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT
- (2010) S Giebel et al. BONE MARROW TRANSPLANTATION
- Rabbit Anti T-Lymphocyte Globulin Induces Apoptosis in Peripheral Blood Mononuclear Cell Compartments and Leukemia Cells, While Hematopoetic Stem Cells Are Apoptosis Resistant
- (2009) Carsten Grüllich et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Role of Missing Killer Cell Immunoglobulin-Like Receptor Ligands in T Cell Replete Peripheral Blood Stem Cell Transplantation from HLA-Identical Siblings
- (2009) Johannes Clausen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation
- (2009) Campbell S Witt CURRENT OPINION IN IMMUNOLOGY
- Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation
- (2009) Sebastian Giebel et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effects of the NK Cell Recovery on Outcomes of Unmanipulated Haploidentical Blood and Marrow Transplantation for Patients with Hematologic Malignancies
- (2008) Ying-Jun Chang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
- (2008) L. Vago et al. BLOOD
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
- (2008) S. Cooley et al. BLOOD
- Donor Killer Immunoglobulin-Like Receptor (KIR) Genotype-Patient Cognate KIR Ligand Combination and Antithymocyte Globulin Preadministration Are Critical Factors in Outcome of HLA-C-KIR Ligand-Mismatched T Cell–Replete Unrelated Bone Marrow Transplantation
- (2007) Toshio Yabe et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation
- (2007) Jennifer Schellekens et al. MOLECULAR IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started